Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Now 'Investigating Possibility' of Selling Genomics Arm; Q2 Revenue Rises and Loss Narrows

NEW YORK (GenomeWeb News) — Gene Logic is “investigating the possibility” of selling “all or parts” of its Genomics business, a slight change in tactics from “considering strategic alternatives” for the unit, which is the language it used as recently as April.
 
Two months before that, the firm said it may create “a spin-off entity with a retained equity position or other alternative structures to capture value for Gene Logic.”
 
Selling all or part of the Genomics business will "likely require” shareholder approval, Gene Logic said. The company has hired investment bank Aquilo Partners to consider its options.
 
Gene Logic made the disclosure in a statement reporting that second-quarter revenues rose 15 percent as R&D spending rose 8 percent and net losses narrowed 30 percent.
 
Total receipts for the three months ended June 30, which came almost entirely from its genomics services business, rose to $5.4 million from $4.7 million year over year.
 
R&D increased to $2.7 million from $2.5 million.
 
The company said net loss decreased to $7.9 million from $11.3 million in the year-ago period.
 
As of June 30, Gene Logic had $20.8 million in combined cash and equivalents and $15.8 million in marketable securities.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.